Baseline comorbidities in patients with rheumatoid arthritis who have been prescribed biological therapy: A case control study Pilar Espiño-Lorenzo, Sara Manrique-Arija, Inmaculada Ureña, Francisco Gabriel Jiménez-Núñez, María López-Lasanta, Carmen María Romero-Barco, María Angeles Belmonte-López, María Victoria Irigoyen, Antonio Fernández-Nebro

Changes in immature granulocyte levels and their association with disease activation following biologic therapy in patients with ankylosing spondylitis Burak Okyar, Servet Yüce, İbrahim Halil Bilen, Bekir Torun, İlyas Öztürk, Gözde Yıldırım Çetin

Comment on: “Safety of biologic and synthetic targeted therapies in patients with immune-mediated diseases: Data from the BIOBADAGUAY registry” Sarah Aijaz, Raveen Muzaffer